Results 41 to 50 of about 189,601 (408)
Journal of the American Medical Association (JAMA), 2018 Importance Anticoagulant choice and proton pump inhibitor (PPI) cotherapy could affect the risk of upper gastrointestinal tract bleeding, a frequent and potentially serious complication of oral anticoagulant treatment. Objectives To compare the incidence
W. Ray +8 more
semanticscholar +1 more source
Preclinical Evaluation of Ureidosulfamate Carbonic Anhydrase IX/XII Inhibitors in the Treatment of Cancers [PDF]
, 2019 Carbonic anhydrases (CAs) are a family of enzymes involved in the pH regulation of metabolically active cells/tissues. Upregulation of the CAIX/XII isoforms is associated with hypoxic tumours and clinically linked with malignant progression, treatment ...
Gieling, Roben, Williams, Kaye J.
core +2 more sources
Risk of Bacterial Infection from Proton Pump Inhibitor Use
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2017 Currently, proton pump inhibitors are used in a wide range of patients with gastroesophageal reflux disease, peptic ulcer, and upper gastrointestinal symptoms such as dyspepsia.
Sung Soo Kim +7 more
doaj +1 more source
Efficacy of
BMC Gastroenterology, 2001 Background Many Helicobacter pylori eradication regimens have been described. There are little data reporting their efficacy or integration in routine clinical practice. The overall results of eradication therapy in a cohort of patients are described and
Beales Ian LP
doaj +1 more source
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Journal of Neurogastroenterology and Motility, 2018 Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for treatment of acid-related diseases including gastroesophageal reflux disease and secondary prevention of aspirin/NSAID-induced ulcers.
Y. Kinoshita, N. Ishimura, S. Ishihara
semanticscholar +1 more source
Eradication of Helicobacter Pylori
Медицинский совет, 2015 General idea. The article is a review of data on Helicobacter pylori resistance to antibiotics, the impact of CYP2C19 polymorphism on the metabolism of proton pump inhibitors, and recent findings on the effectiveness of eradication.
V. V. Tsukanov +3 more
doaj +1 more source
South African Family Practice, 2015 Proton-pump inhibitors (PPIs) are a class of drugs that profoundly suppress gastric acid secretion, and thus have become the treatment of choice for gastro-oesophageal reflux disease and peptic ulcer disease. PPIs are considered safe and effective. It is essential that clinicians understand the appropriate use of PPIs, given the significant economic ...
openaire +4 more sources
No proton pump inhibitors? [PDF]
BMJ, 2007 Hickson et al have tried to introduce true scientific method in an area chiefly governed by sales tactics and mass advertising, but it is good to see their admission regarding …
openaire +2 more sources
Proton pump inhibitors overuse - consequences among patients
Journal of Education, Health and Sport, 2019 Introduction Omeprazole was first proton pump inhibitor (PPI) approved for use by patients. Thirty years have passed since then. Due to their effectiveness, low price and safety proton pump inhibitors have become one of the most frequently prescribed ...
Patrycja Kmiotek +2 more
doaj +3 more sources
Clopidogrel and proton pump inhibitors [PDF]
Canadian Medical Association Journal, 2014 The points raised by Juurlink[1][1] in response to our article[2][2] are worthy of consideration. The release kinetics of the drugs as given in the COGENT trial may have attenuated the potential for a drug–drug interaction.
openaire +7 more sources